Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Key Points. Patients with abnl(17p) AML have a poor outcome after allogeneic hematopoietic stem cell transplantation.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
March 20, 2014
|
| In: |
Blood
Year: 2014, Volume: 123, Issue: 19, Pages: 2960-2967 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2013-12-544957 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood-2013-12-544957 Verlag, lizenzpflichtig, Volltext: https://ashpublications.org/blood/article/123/19/2960/32653/Outcome-of-patients-with-abnl-17p-acute-myeloid |
| Author Notes: | Jan M. Middeke, Min Fang, Jan J. Cornelissen, Brigitte Mohr, Frederick R. Appelbaum, Michael Stadler, Jaime Sanz, Herrad Baurmann, Gesine Bug, Kerstin Schäfer-Eckart, Ute Hegenbart, Tilmann Bochtler, Christoph Röllig, Friedrich Stölzel, Roland B. Walter, Gerhard Ehninger, Martin Bornhäuser, Bob Löwenberg, and Johannes Schetelig |
| Summary: | Key Points. Patients with abnl(17p) AML have a poor outcome after allogeneic hematopoietic stem cell transplantation. |
|---|---|
| Item Description: | Gesehen am 24.08.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2013-12-544957 |